Company
Beeline Medicines Corporation
| Industry | clinical-stage biotechnology company focused on developing and delivering precision therapies for people with autoimmune and inflammatory diseases |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Beeline Medicines Corporation | Series A | 2026-07-06 |
| Beeline Medicines Corporation | Series A | 2026-04-16 |